Biosensis specializes in antibodies and reagents for neuroscience, with a special emphasis on neurotrophins and neurotrophin receptors. In addition to neurotrophins, Biosensis’ neuroscience portfolio includes products for neurodegenerative disease, neurodevelopmental, and neurometabolism research.
Other areas of interest are Alzheimer’s, Parkinson’s and ALS diseases, as well as autophagy, cancer, diabetes and obesity, glia, neuroimmunology and inflammation and stem cell research.
Biosensis’ offering includes antibodies for neuroscience research, over 200 quantitative ELISA kits, reagents for tissue staining and cell visualization, and purified proteins intended for research in neuroscience and cellular diseases, many of which have been used in peer-reviewed research publications.
